Aryl sulfones:: a new class of γ-secretase inhibitors

被引:97
作者
Teall, M
Oakley, P
Harrison, T
Shaw, D
Kay, E
Elliott, J
Gerhard, U
Castro, JL
Shearman, M
Ball, RG
Tsou, NN
机构
[1] Neurosci Res Ctr, Merck Sharp & Dohme Res Labs, Dept Med Chem, Harlow CM20 2QR, Essex, England
[2] Neurosci Res Ctr, Merck Sharp & Dohme Res Labs, Dept Mol & Cellular Neurosci, Harlow CM20 2QR, Essex, England
[3] Merck & Co Inc, Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
关键词
D O I
10.1016/j.bmcl.2004.12.017
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The development of a novel series of 4-aryl, 4-phenylsulfonyl cyclohexananone-derived gamma-secretase inhibitors for the potential treatment of Alzheimer's disease is described. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2685 / 2688
页数:4
相关论文
共 26 条
[1]  
ASBEROM T, 2003, Patent No. 014075
[2]  
AUDIA J, 1999, Patent No. 66934
[3]  
AUDIA J, 1999, Patent No. 67219
[4]   It all sticks together - the APP-related family of proteins and Alzheimer's disease [J].
Bayer, TA ;
Cappai, R ;
Masters, CL ;
Beyreuther, K ;
Multhaup, G .
MOLECULAR PSYCHIATRY, 1999, 4 (06) :524-528
[5]   UNUSUAL STEREOCHEMICAL RESULTS IN THE REACTION OF ALPHA-LITHIO DERIVATIVES OF BICYCLIC SULFOXIDES [J].
BEN, RN ;
BREAU, L ;
BENSIMON, C ;
DURST, T .
TETRAHEDRON, 1994, 50 (20) :6061-6076
[6]   Quantitation of amyloid-β peptides in biological milieu using a novel homogeneous time-resolved fluorescence (HTRF) assay [J].
Clarke, EE ;
Shearman, MS .
JOURNAL OF NEUROSCIENCE METHODS, 2000, 102 (01) :61-68
[7]   β-amyloid peptide as a target for treatment of Alzheimer's disease [J].
Conde, S .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (04) :503-512
[8]   Secretases as therapeutic targets for the treatment of Alzheimer's disease [J].
Dominguez, DI ;
De Strooper, B ;
Annaert, W .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 (02) :124-142
[9]   CONFORMATIONAL-ANALYSIS .40. CONFORMATION OF 1-METHYL-1-PHENYLCYCLOHEXANE AND THE CONFORMATIONAL ENERGIES OF THE PHENYL AND VINYL GROUPS [J].
ELIEL, EL ;
MANOHARAN, M .
JOURNAL OF ORGANIC CHEMISTRY, 1981, 46 (09) :1959-1962
[10]   Alzheimer's disease-affected brain:: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss [J].
Gong, YS ;
Chang, L ;
Viola, KL ;
Lacor, PN ;
Lambert, MP ;
Finch, CE ;
Krafft, GA ;
Klein, WL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) :10417-10422